Variation Biotechnologies Inc.

7 articles about Variation Biotechnologies Inc.

• 

  BioSpace Global Roundup, Aug. 6

  8/6/2020

  Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.

• VBI Vaccines Awarded Up to CAD$56 Million Contribution from Canadian Government to Accelerate Coronavirus Vaccine Development

  8/5/2020

  - Government of Canada will support advancement of VBI’s coronavirus program through Phase 2 clinical development - Pre-clinical data are expected to enable selection of clinical candidates in Q3 2020 and the initiation of clinical studies by the end of 2020

• Variation Biotechnologies Inc. And Paulson Capital Announce Completion Of Merger

  7/28/2014

• Variation Biotechnologies Inc. to Present at the 22nd Annual Piper Jaffray Health Care Conference

  11/23/2010

• Variation Biotechnologies Inc. Names Jeff Baxter CEO

  9/22/2009

• Variation Biotechnologies Inc. to Present Positive Influenza Vaccine Data at the 49th Annual ICAAC Meeting

  9/11/2009

• Burns & Levinson's Canadian Subsidiary Helps Variation Biotechnologies Inc. Land More Than $35 Million In Venture Capital Funding

  2/1/2007